Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WDC vs GSK✓SelectedUSD · GSKWDC vs GSK performance historyLatest closeAs of+2.98%11/19
Stock and ETF performance explorer

WDC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+604.3%
GSK return
+39.6%
Excess return
+564.8%
Maximum drawdown
-64.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+3.0%-1.6%+4.5%+3.1%
7D-4.6%-4.7%+0.1%-4.4%
30D-18.5%-4.7%-13.8%-18.3%
3M-35.8%-8.8%-27.0%-35.3%
6M-34.9%-4.6%-30.2%-35.1%
YTD+72.5%+1.0%+71.5%+69.9%
1Y+93.1%+6.9%+86.2%+88.2%
3Y+746.3%+52.5%+693.8%+651.7%
5Y+604.3%+40.3%+564.0%+502.7%
All+604.3%+39.6%+564.8%+502.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling